Steven George Hughes
Chief Medical Officer, VivoSim Labs, INC.
Companies
- Atrium Therapeutics, Inc.Chief Medical Officer Feb 26, 2026 to now1
- Avidity Biosciences, Inc.Chief Medical Officer Jan 8, 2025 to now2
- Arcturus TherapeuticsChief Development Officer Feb 20, 2020 to Dec 22, 20203
- VivoSim Labs, INC.Chief Medical Officer Aug 9, 2018 to Aug 19, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Atrium Therapeutics, Inc. RNA51,638 shares5$398.6K at $7.72Sep 18, 2026
- Avidity Biosciences, Inc.0 shares6Feb 27, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 18, 2026Shares withheld for tax 21,459 shares at $8.95 of Atrium Therapeutics, Inc.5
- Apr 20, 2026Granted 30,000 shares of Atrium Therapeutics, Inc.7
- Feb 27, 2026Returned to company 115,857 shares of Avidity Biosciences, Inc.6
- Jan 21, 2026Sold 2,878 shares at $72.45 of Avidity Biosciences, Inc.8
- Jan 21, 2026Sold 2,017 shares at $72.45 of Avidity Biosciences, Inc.8
- Jan 7, 2026Sold 2,373 shares at $72.23 of Avidity Biosciences, Inc.9
- Oct 22, 2025Sold 2,209 shares at $47.54 of Avidity Biosciences, Inc.10
- Oct 22, 2025Exercised options 2,209 shares at $10.16 of Avidity Biosciences, Inc.10
- Sep 22, 2025Sold 2,208 shares at $40.58 of Avidity Biosciences, Inc.11
- Sep 22, 2025Exercised options 2,208 shares at $10.16 of Avidity Biosciences, Inc.11
- Sep 15, 2025Sold 1,542 shares at $45.41 of Avidity Biosciences, Inc.12
- Sep 15, 2025Exercised options 1,542 shares at $6.57 of Avidity Biosciences, Inc.12
- Aug 22, 2025Sold 2,208 shares at $46.40 of Avidity Biosciences, Inc.13
- Aug 22, 2025Exercised options 2,208 shares at $10.16 of Avidity Biosciences, Inc.13
- Aug 13, 2025Sold 1,542 shares at $46.66 of Avidity Biosciences, Inc.14
- Aug 13, 2025Exercised options 1,542 shares at $6.57 of Avidity Biosciences, Inc.14
- Aug 6, 2025Sold 33,983 shares at $42.74 of Avidity Biosciences, Inc.15
- Aug 6, 2025Sold 17,667 shares at $42.74 of Avidity Biosciences, Inc.15
- Aug 6, 2025Exercised options 17,667 shares at $10.16 of Avidity Biosciences, Inc.15
- Aug 6, 2025Sold 6,167 shares at $42.74 of Avidity Biosciences, Inc.15
- Aug 6, 2025Exercised options 6,167 shares at $22.47 of Avidity Biosciences, Inc.15
- Aug 6, 2025Sold 12,334 shares at $42.74 of Avidity Biosciences, Inc.15
- Aug 6, 2025Exercised options 12,334 shares at $6.57 of Avidity Biosciences, Inc.15
- Aug 6, 2025Sold 11,283 shares at $42.74 of Avidity Biosciences, Inc.15
- Aug 6, 2025Exercised options 11,283 shares at $15.96 of Avidity Biosciences, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Apr 22, 2026
- 8SEC EDGARForm 4 filed Jan 23, 2026
- 9SEC EDGARForm 4 filed Jan 9, 2026
- 10SEC EDGARForm 4 filed Oct 24, 2025
- 11SEC EDGARForm 4 filed Sep 23, 2025
- 12SEC EDGARForm 4 filed Sep 17, 2025
- 13SEC EDGARForm 4 filed Aug 22, 2025
- 14SEC EDGARForm 4 filed Aug 15, 2025
- 15SEC EDGARForm 4 filed Aug 8, 2025